CLDN5 and depressive symptom measurement: Postmortem human studies also suggest that CLDN5 expression is substantially reduced in the nucleus accumbens from untreated depressed men and women (Menard et al., 2017), and in the ventromedial prefrontal cortex (vmPFC) of women with depression (Dion-Albert et al., 2022).